P. Senico - Concepedia

Author

P. Senico

Also Known As

P. Senico, Peggy L. Senico, Peggy Senico

Publications

649

Citations

H-Index

Concepts

All Affiliations

P. Senico is an author at Pfizer (United States) specializing in oncology, radiation oncology, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	244
2	Surgical Oncology	2	2	230
3	Cancer Therapeutics	2	2	77
4	Pharmacology	1	1	14
5	Molecular Oncology	1	1	14

P. Senico

Publications

641

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma Thomas E. Hutson, Bernard Escudier, Emilio Esteban, Journal of Clinical Oncology	2013	397
Phase I Study Combining Treatment with Temsirolimus and Sunitinib Malate in Patients with Advanced Renal Cell Carcinoma Premal H. Patel, P. Senico, Rafael E. Curiel, Clinical Genitourinary Cancer UrologySurgical OncologySunitinib MalateGenitourinary CancerMedicine	2009	167
Temsirolimus vs Sorafenib As Second Line Therapy in Metastatic Renal Cell Carcinoma: Results from the Intorsect Trial Thomas E. Hutson, Bernard Escudier, Georg A. Bjarnason, Annals of Oncology UrologySurgical OncologyGenitourinary CancerMedicineTemsirolimus Vs Sorafenib	2012	63
P3.02b-001 Phase 1 Dose Escalation of PF-06747775 (EGFR-T790M Inhibitor) in Patients with Advanced EGFRm (Del 19 or L858R+/-T790M) NSCLC Hatim Husain, Renato Martins, Sarah B. Goldberg, Journal of Thoracic Oncology Advanced EgfrmDel 19Dose EscalationMedicinePharmacology	2017	14

Page 1